Advertisement

Topics

Cerus Corporation Reports Fourth Quarter and Year End 2016 Results

16:01 EST 7 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Cerus Corporation (NASDAQ:CERS) today announced financial results for the fourth quarter and year ended December 31, 2016. Recent developments include: The U.S. Food and Drug Administration's Center fo...

Other Sources for this Article

Cerus Corporation
Kevin Green, 925-288-6138
Vice President, Finance and Chief Financial Officer

NEXT ARTICLE

More From BioPortfolio on "Cerus Corporation Reports Fourth Quarter and Year End 2016 Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...